A preprint of the study by researchers of Oxford University noted that a third dose of the AstraZeneca vaccine will also lead to a substantial increase in immune response.
UK’s drug regulator is investigating rare cases of blood clots in adults who were given Oxford-AstraZeneca shot. No safety issues have arisen in children’s trial, Oxford says.
Amid reports that doses were causing blood clot-related complications, Johnson said that six months since its discovery, multiple countries like India are producing the vaccine.
According to Oxford University researchers, the first dose of the vaccine offers 76% protection, making it safe for the interval between doses to be extended to 3 months.
India’s vaccination strategy is smartly-designed and will strengthen healthcare workers to handle a second wave, says Dr V. Ravi, former basic sciences dean at NIMHANS.
Bharat Biotech MD Dr Krishna Ella says they gave ‘excellent safety data tested on around 25,000 participants’ & their efficacy data will be available by February-March.
Our cities are struggling because they are treated as outposts of an empire--administered by unaccountable viceroys and dangerous to the people forced to live in them.
Sectoral insight report says while clean mobility transition is technically possible, India’s current transport system is not aligned towards the vision. It recommends a phased strategy.
By next weekend, Bangladesh will have an elected government. This is India’s moment to reboot broken ties by moderating the ‘ghuspethiya’ rhetoric in poll-bound West Bengal and Assam.
COMMENTS